Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Heckmann Sundhed ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 1.5% 0.6%   Bankruptcy risk   5.3% 4.9% 2.4% 2.9% 2.9% 2.8% 12.0% 10.0%   Credit score (0-100)   43 46 64 57 58 59 20 25   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   678 686 0 0 0 0 0 0   Gross profit   615 587 654 821 785 826 0.0 0.0   EBITDA   157 162 193 341 323 358 0.0 0.0   EBIT   153 119 149 298 283 358 0.0 0.0   Pre-tax profit (PTP)   153.2 117.2 176.7 377.2 259.5 460.9 0.0 0.0   Net earnings   119.0 90.3 137.0 293.1 202.2 358.4 0.0 0.0   Pre-tax profit without non-rec. items   153 117 177 377 260 461 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   170 127 83.3 39.9 0.0 0.0 0.0 0.0   Shareholders equity total   403 494 631 924 1,126 1,484 1,434 1,434   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   505 594 763 1,054 1,197 1,612 1,434 1,434   Net Debt   -275 -219 -667 -957 -1,093 -1,491 -1,434 -1,434     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   678 686 0 0 0 0 0 0   Net sales growth   -3.0% 1.2% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   615 587 654 821 785 826 0.0 0.0   Gross profit growth   -3.3% -4.5% 11.4% 25.6% -4.4% 5.2% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   505 594 763 1,054 1,197 1,612 1,434 1,434   Balance sheet change%   37.8% 17.6% 28.5% 38.0% 13.6% 34.6% -11.0% 0.0%   Added value   156.9 162.2 192.7 341.4 326.5 357.9 0.0 0.0   Added value %   23.1% 23.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   167 -87 -87 -87 -80 0 0 0   Net sales trend   -2.0 1.0 -1.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   23.1% 23.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   22.6% 17.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.9% 20.2% 22.8% 36.3% 36.0% 43.3% 0.0% 0.0%   Net Earnings %   17.6% 13.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   18.1% 19.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   22.6% 17.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   35.2% 21.7% 26.3% 42.3% 25.1% 32.9% 0.0% 0.0%   ROI %   44.6% 26.6% 31.7% 49.5% 27.6% 35.4% 0.0% 0.0%   ROE %   34.6% 20.1% 24.4% 37.7% 19.7% 27.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   79.8% 83.1% 82.6% 87.7% 94.0% 92.1% 100.0% 100.0%   Relative indebtedness %   15.0% 14.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   -25.6% -17.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -175.6% -135.0% -346.0% -280.3% -338.4% -416.6% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.3 2.7 5.1 7.8 16.8 12.6 0.0 0.0   Current Ratio   3.3 2.7 5.1 7.8 16.8 12.6 0.0 0.0   Cash and cash equivalent   275.5 219.0 666.6 956.9 1,092.7 1,490.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   31.9 23.8 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   49.4% 38.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   233.2 166.2 17.4 882.9 541.3 795.8 0.0 0.0   Net working capital %   34.4% 24.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 358 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 358 0 0   EBIT / employee   0 0 0 0 0 358 0 0   Net earnings / employee   0 0 0 0 0 358 0 0